USMS Narcan/Naloxone Kit
ID: 15M10424QA4700009Type: Combined Synopsis/Solicitation
Overview

Buyer

JUSTICE, DEPARTMENT OFUS MARSHALS SERVICEOFFICE OF PROCUREMENT, OPERATIONAL SUPPORT SECTION – A47LANDOVER, MD, 20785, USA

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

PSC

REPLENISHABLE FIELD MEDICAL SETS, KITS, AND OUTFITS (6545)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/21be1312b5aa4231ab447f1c32732c23/view
Timeline
    Description

    The Department of Justice, specifically the United States Marshals Service (USMS), is seeking qualified small businesses to establish a Blanket Purchase Agreement (BPA) for the procurement of Narcan/Naloxone kits and related opioid reversal medications and equipment as part of its Opioid Reversal Program. The BPA will allow USMS Districts and Divisions to order these essential supplies on an as-needed basis, enhancing their operational readiness to respond to opioid-related incidents. This initiative reflects the USMS's commitment to addressing the opioid crisis effectively, with an anticipated performance period from March 15, 2025, to March 14, 2030, including one base year and four optional years. Interested parties must submit their quotes by 1:00 PM EST on February 14, 2025, and direct any inquiries to Kim Ramsay at kim.ramsay2@usdoj.gov.

    Point(s) of Contact
    Kim Ramsay
    (771) 201-1680
    kim.ramsay2@usdoj.gov
    Files
    Title
    Posted
    15M10424QA4700009 FINAL.pdf
    The document is a solicitation for the procurement of Narcan kits by the United States Marshals Service (USMS), identified by solicitation number 15M10424QA4700009. It outlines the request for quotations (RFQ) specifically set aside for small businesses, particularly those categorized as HubZone, service-disabled veteran-owned, and women-owned. The document specifies the request for various Narcan kits, pricing terms, contract provisions, and delivery requirements, emphasizing the need for firm fixed prices. Key components include contract terms and conditions, compliance with federal laws, invoicing requirements, breach and indemnification clauses, and confidentiality agreements. The document instructs the contractor to keep all confidential information secure, and it outlines the requirements for payment and contract administration, highlighting the urgency of timely invoice submission for small businesses as mandated by the Office of Management and Budget. Overall, it illustrates the government's commitment to sourcing vital emergency medical supplies while ensuring adherence to regulations, efficiency in processing, and the protection of sensitive information.
    Attachment 2 - Instructions to Offerors Final.pdf
    The government solicitation seeks to establish a firm fixed-price Single Award Blanket Purchase Award (SA-BPA) specifically for small businesses to supply Narcan kits. Submission inquiries must be directed to the designated email by a specified deadline. Offerors are required to ensure no organizational conflicts of interest exist and to disclose any relevant facts. The proposal must include a PowerPoint presentation, technical specifications, and a Management Plan detailing how requirements will be met. Pricing must be submitted using an attached Excel workbook and must encompass shipping costs. Offers must be submitted by February 14, 2025, with the potential award based on the lowest price for technically acceptable bids that meet all necessary criteria. The selection process emphasizes adherence to the specifications outlined in the Statement of Work, ensuring contractor eligibility and proposal integrity under FAR regulations. The document underscores the government’s commitment to engaging small businesses through structured guidelines to facilitate the procurement of essential public health resources.
    Attachment Pricing Spreadsheet.xlsx
    The government file outlines a Request for Proposal (RFP) for a series of medical kits intended for emergency response, specifically regarding the administration of Naloxone/Narcan, an opioid overdose reversal medication. The document details multiple product lines, including a complete kit, a kit without Naloxone, and two versions of restock kits, distributed across five distinct years, including option years. Each item is assigned a unique line item number (CLIN) for tracking purposes. The estimated quantities include a total of 4000 complete kits to be issued, alongside smaller quantities of other kits, with a collective pricing structure currently marked as $0.00, indicating that financial details may be pending or unspecified. The structure is methodical, delineating base and option year requirements, emphasizing preparedness for potential future needs in emergency medical situations. This document serves as a crucial step in equipping responders with necessary resources while highlighting the commitment to address public health emergencies effectively.
    Statement of Work Narcan Final.pdf
    The United States Marshals Service (USMS) seeks to establish a Blanket Purchase Agreement (BPA) to supply opioid reversal medications and equipment under its Opioid Reversal Program. The BPA, set aside for small businesses, provides a procurement framework for USMS Districts and Divisions to order Naloxone (Narcan) kits and supplies as needed. The agreement will follow a Firm-Fixed-Price structure, with pricing set at the BPA award, and necessitates no upfront funding commitment by the government. Key deliverables include various types of kits (Complete Kit, Restock Kit V1, and V2) that contain specified equipment and medications, with estimated quantities for base and option years detailed. Orders will ship to multiple USMS locations, following strict timelines based on quantity. The BPA’s period of performance spans one year, with four additional optional years. This initiative aims to enhance operational readiness for opioid-related incidents, reflecting USMS’s commitment to addressing the opioid crisis effectively.
    Lifecycle
    Title
    Type
    USMS Narcan/Naloxone Kit
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    USMS IDIQ Body Armor
    Active
    Justice, Department Of
    The U.S. Marshals Service (USMS), part of the Department of Justice, is seeking proposals for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to procure body armor for its Deputy U.S. Marshals. The primary objective of this procurement is to provide ballistic protective systems, including tactical vests and ballistic inserts, essential for the safety and operational effectiveness of law enforcement personnel engaged in various judicial protection activities. This contract is crucial for ensuring that USMS personnel are equipped with high-quality protective gear as they fulfill their responsibilities, which include court security and fugitive apprehension. Interested vendors must submit their proposals by November 1, 2024, and can direct inquiries to Julie Simpson at julie.simpson@usdoj.gov. The contract will be awarded based on technical merit and cost-effectiveness, with a potential total value spanning multiple years.
    USMS FY25 IOD/CARFTF AXON Sky-Hero Robots
    Active
    Justice, Department Of
    The U.S. Marshals Service, part of the Department of Justice, is soliciting proposals for the procurement of Axon Sky-Hero Robots under solicitation number 15M10225QA4700024. This opportunity aims to acquire advanced robotic products that meet specific technical specifications, enhancing the operational capabilities of the U.S. Marshals Service while ensuring compliance with federal regulations and ethical standards. The procurement is critical for improving tactical operations and safety measures within the agency. Interested vendors must submit their quotes and complete the required documentation by following the instructions outlined in the solicitation, with inquiries directed to Jennifer Brite at jennifer.brite@usdoj.gov or Kate Oravitz-Weeks at Kathryn.Oravitz-Weeks@usdoj.gov.
    Safety Station Program
    Active
    Justice, Department Of
    The Department of Justice, through the Executive Office for Immigration Review (EOIR), is seeking proposals for the Safety Station Program, aimed at enhancing emergency preparedness across approximately 60 locations. The contractor will be responsible for providing and installing safety stations equipped with FDA-approved Automated External Defibrillators (AEDs), opioid reversal agents, and hemorrhagic control kits, along with training personnel in CPR, AED usage, and emergency response techniques. This initiative underscores the government's commitment to public safety and compliance with federal guidelines, ensuring a proactive approach to health emergencies within EOIR facilities. Interested vendors must submit their bids by January 3, 2025, with the contract expected to commence on January 6, 2025, and extend through January 5, 2030, with a total contract duration of up to 66 months. For further inquiries, contact Andrew Byrnes at andrew.byrnes@usdoj.gov or 703-605-1739.
    15BCTS25R00000003 - SU/MH/SOT in Baltimore
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons, is seeking a contractor to provide community-based outpatient treatment services for substance use disorders, mental health, and sex offender treatment for adults in custody in Baltimore, Maryland. The services will be delivered by licensed clinicians within a ten-mile radius of the Baltimore Federal Courthouse, ensuring accessibility to public transportation. This contract, which is set aside for small businesses, includes a one-year base period starting April 1, 2025, with four additional one-year options, and the estimated closing date for proposals is around February 10, 2024. Interested parties can direct inquiries to Coretta MaGee at cmagee@bop.gov or Gary L. Clark at g3clark@bop.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotations for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) related to the procurement of pharmaceutical agents as part of its Uniform Formulary (UF) initiative. This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of newly approved drugs across various therapeutic classes, including neurological agents, antibiotics, oncological agents, and more. The selected pharmaceutical agents will be evaluated by the Pharmacy and Therapeutics (P&T) Committee during meetings scheduled for February 5-6, 2025, with quotes due by January 16, 2025. Interested manufacturers should submit their quotes and any required documentation to the designated contacts, Tracy Banks and Patricia Tyson, at the provided email addresses.
    Bulk Pharma Group B
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of a range of FDA-approved pharmaceuticals as part of the Bulk Pharma Group B initiative. The contract will require the delivery of specific injectable medications, including Acyclovir Sodium, Doxycycline, Levophed, Meropenem, Sodium Chloride, and sterile water, with quantities detailed in the attached Request for Proposal (RFP). This procurement is critical for maintaining the Strategic National Stockpile, ensuring a reliable supply of essential pharmaceuticals for disaster preparedness and response efforts. Interested vendors must submit their proposals by the specified deadline, and inquiries can be directed to primary contact Terri Reed at terri.reed@hhs.gov or secondary contact Kimberly Golden at kimberly.golden1@hhs.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    DA10--VISN 10 Pharmacy | Methasoft Software Maint. and Support
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to NetSmart Technologies, Inc. for the maintenance and support of the Methasoft software, which is crucial for managing methadone and opioid substitution therapies in various veterans' clinics. The contractor will be responsible for providing comprehensive technical support 24/7, including necessary software updates and upgrades, to ensure compliance with regulations regarding controlled opioid substitution treatments. This software is currently utilized in multiple VA Medical Centers, including those in Cincinnati, Cleveland, Dayton, Detroit, and Indianapolis. Interested firms capable of meeting these requirements may submit their qualifications to the designated Contract Specialist, Teri Miller, via email by January 10, 2025, at 1:00 PM (ET). The procurement falls under NAICS code 541519, with a standard size requirement of $34 million.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0111 770-25-2-801-0179 -National CMOP S0174 SUMATRIPTAN 6MG
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply Sumatritpan 6mg/0.5ml injection syringes as part of an emergency procurement for its National CMOP (Contract Management Office Product) facilities. The requirement includes multiple quantities of the specified pharmaceutical product, with a total of 600 to 2400 units per item, to be delivered within 10 days after receipt of order to various CMOP locations. This procurement is critical for ensuring the availability of essential medications for veterans, and compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory, requiring vendors to provide necessary documentation, including state wholesale distributor licenses. Interested parties must submit their quotations by January 14, 2025, with the contract award anticipated on January 17, 2025; for further details, vendors can contact Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.